Latest News
Investor Relations
Latest News
August 29, 2024 07:00 am
BioStem Technologies, Inc. to Present at the H.C. Wainwright 26th Annual Global Investment Conference in New York on September 9th at 3:30 PM ET
August 21, 2024 07:00 am
BioStem Receives Institutional Review Board (IRB) Approval to Advance Clinical Study Evaluating the Value of Vendaje® Compared to the Standard of Care for Non-Healing Diabetic Foot Ulcers
August 12, 2024 04:14 pm
BioStem Technologies Reports Record Second Quarter 2024 Revenue of $74.5 Million
August 5, 2024 08:00 am
BioStem Technologies to Report Second Quarter 2024 Financial Results on Monday, August 12, 2024
July 16, 2024 08:12 am
BioStem Technologies Inc. In A Race To The Top With Innovative Wound-Care Treatments
July 10, 2024 07:15 am
BioStem Receives Institutional Review Board (IRB) Approval to Advance a Clinical Study Evaluating AmnioWrap2(TM) in Diabetic Foot Ulcers
June 26, 2024 08:30 am
BioStem Technologies Reports Breakthrough Results with AmnioWrap2® in Retrospective Wound Care Study
June 17, 2024 02:07 pm
UPDATE -- PRISM MarketView Showcases BioStem Technologies: Impressive Revenue Growth and Strategic Expansion
May 29, 2024 11:00 am
BioStem Technologies to Sponsor MRO Better Half Dash
May 14, 2024 04:01 pm